Southwest Oncology Group

西南肿瘤组

• 批准号: 7563950
• 负责人: LAWRENCE E FLAHERTY
• 金额: $ 22.1万
• 依托单位: WAYNE STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1978
• 资助国家: 美国
• 起止时间: 1978-01-01 至 2009-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7563950
• 关键词: Area; Award; Chairperson; Chemoprevention; Clinical Research; Clinical Trials; Disease; Enrollment; Evaluation; Faculty; Goals; Grant; Individual; Institution; Leadership; Malignant Neoplasms; Manuscripts; Minority; Nurses; Organ; Patients; Performance; Physicians; Play; Principal Investigator; Research; Research Personnel; Role; Southwest Oncology Group; Translations; Universities; Woman; abstracting; demographics; meetings; melanoma; member; multidisciplinary; programs

DESCRIPTION (provided by applicant): Wayne State University (WSU) has been an active institutional member of the Southwest Oncology Group for over 30 years, enrolling over 4000 patients onto clinical trials. Over these years, our faculty have played an important role in support of SWOG, by providing leadership in the administrative and scientific functions of SWOG, and also by meeting and exceeding patient accrual goals in a continuous and consistent manner. Thus, WSU has remained in the first quartile of institution's performance evaluation conducted by SWOG in each of the last five years. The clinical research program in cancer at WSU has been organized along the lines of multidisciplinary disease oriented studies and in a manner that resembles the organ committee orientation of SWOG. Thus, our faculty's representation in scientific SWOG committees is constituted by individuals with expertise and commitment toward those areas of research. Accordingly, the translation of ideas into SWOG studies as well as the incorporation of SWOG studies and those of NCI designated high priority trials into WSU treatment priorities, are easily facilitated. In addition, the demographics of our region and the commitment of investigators to make clinical trials available to all patients, is clearly identified in our recruitment of minorities (27%) and women (61%) into SWQG clinical trials. The SWOG membership in WSU and the diversity of disciplinary involvement by our faculty has continued to grow over the years. To date over 100 WSU members are currently serving on over 40 committees. Similarly, 50 SWOG studies list a WSU member as a study primary coordinator or co-coordinator since the last competing application was submitted. Fifth three abstracts and 56 manuscripts have had WSU faculty as primary or co-authors. Six WSU physician faculty and 3 nurses hold 14 committee administrative roles. Since the last competitive renewal WSU has been awarded NCl supplemental grants for chemoprevention and minority recruitment. Dr. Lawrence Flaherty, a SWOG member since 1986 and Vice-Chairman of the SWOG Melanoma Committee, has been the Principal Investigator since 1996 and has maintained the prominence of WSU as a SWOG member institution.

描述（由申请人提供）：韦恩州立大学（WSU）已成为西南肿瘤学集团的活跃机构成员已有30多年的历史，将4000多名患者纳入临床试验。这些年来，我们的教职员工在支持Swog，通过在Swog的行政和科学职能方面以及以连续且一致的方式实现并超越患者应计目标的领导来支持SWOG。因此，在过去五年中，WSU一直留在机构绩效评估的第一个四分位数中。 WSU癌症的临床研究计划已按照多学科疾病的研究以及类似于器官委员会swog的方向的方式进行了组织。因此，我们的教师在科学掠夺委员会中的代表是由对这些研究领域的专业知识和承诺的人组成的。因此，很容易促进思想转化为摇摆研究以及吞噬研究的纳入研究的纳入研究，并将其指定的高优先级试验指定为WSU治疗重点。此外，在我们招募少数民族（27％）和SWQG临床试验中，清楚地发现了我们地区的人口统计以及研究人员对所有患者进行临床试验的承诺。多年来，WSU的Swog会员资格以及我们教职员工的纪律参与程度一直在增长。迄今为止，超过100个WSU成员目前正在40多个委员会任职。同样，自从提交了最后一次竞争申请以来，有50项SWOG研究将WSU成员列为研究主要协调员或协调员。第五三个摘要和56个手稿将WSU教师作为主要或合着者。六个WSU医师教师和3名护士担任14个委员会行政职务。自从上次竞争性更新WSU以来，WSU已获得NCL补充赠款，以进行化学预防和少数族裔招募。自1986年以来，SWOG成员劳伦斯·弗拉赫蒂（Lawrence Flaherty）博士，SWOG黑色素瘤委员会的副主席，自1996年以来一直是主要研究人员，并一直保持WSU作为SWOG成员机构的突出性。